Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant herpes zoster vaccine (CHO cell)

recombinant herpes zoster vaccine · MAXVAX Biotechnology Limited Liability Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant herpes zoster vaccine (CHO cell), covering 2024-11-20 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older [Phase 1, Phase 2]

See pricing